BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30280491)

  • 1. Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan.
    Yeh TC; Liang DC; Liu HC; Jaing TH; Chen SH; Hou JY; Yang CP; Huang YJ; Yao HW; Huang TY; Lin TH; Shih LY
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27496. PubMed ID: 30280491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.
    Wang Q; Qiu H; Jiang H; Wu L; Dong S; Pan J; Wang W; Ping N; Xia J; Sun A; Wu D; Xue Y; Drexler HG; Macleod RA; Chen S
    Haematologica; 2011 Dec; 96(12):1808-14. PubMed ID: 21880637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex reverse transcription-polymerase chain reaction as diagnostic molecular screening of 4 common fusion chimeric genes in Taiwanese children with acute lymphoblastic leukemia.
    Yang YL; Lin SR; Chen JS; Hsiao CC; Lin KH; Sheen JM; Cheng CN; Wu KH; Lin SW; Yu SL; Chen HY; Lu MY; Chang HH; Yen CT; Lin JF; Su YH; Li YP; Lin CY; Jou ST; Lin DT
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e323-30. PubMed ID: 20930648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
    Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
    Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome.
    Mansur MB; Emerenciano M; Brewer L; Sant'Ana M; Mendonça N; Thuler LC; Koifman S; Pombo-de-Oliveira MS
    Leuk Lymphoma; 2009 Aug; 50(8):1318-25. PubMed ID: 19562638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia.
    Chang YH; Yu CH; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Chang HH; Lin DT; Lin SW; Chen HY; Yang YL
    Sci Rep; 2021 Jan; 11(1):769. PubMed ID: 33436855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of SET-NUP214 fusion gene in patients with T-cell acute lymphoblastic leukemia and its clinical significance].
    Dai HP; Wang Q; Wu LL; Ping NN; Wu CX; Xie JD; Pan JL; Xue YQ; Wu DP; Chen SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1047-51. PubMed ID: 23114116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
    Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
    BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABL1 rearrangements in T-cell acute lymphoblastic leukemia.
    Hagemeijer A; Graux C
    Genes Chromosomes Cancer; 2010 Apr; 49(4):299-308. PubMed ID: 20073070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene mutation profiles and prognostic implications in Korean patients with T-lymphoblastic leukemia.
    Huh HJ; Lee SH; Yoo KH; Sung KW; Koo HH; Jang JH; Kim K; Kim SJ; Kim WS; Jung CW; Lee KO; Kim SH; Kim HJ
    Ann Hematol; 2013 May; 92(5):635-44. PubMed ID: 23354995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between expression of SIL-TAL1 fusion gene and deletion of 6q in T-cell acute lymphoblastic leukemia].
    Wang Q; Wu LL; Dai HP; Ping NN; Wu CX; Pan JL; Cen JN; Qiu HY; Chen SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1508-13. PubMed ID: 25543465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia.
    Agarwal M; Bakhshi S; Dwivedi SN; Kabra M; Shukla R; Seth R
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27001. PubMed ID: 29446543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia.
    Alcantara M; Simonin M; Lhermitte L; Touzart A; Dourthe ME; Latiri M; Grardel N; Cayuela JM; Chalandon Y; Graux C; Dombret H; Ifrah N; Petit A; Macintyre E; Baruchel A; Boissel N; Asnafi V
    Blood Adv; 2019 Jul; 3(13):1981-1988. PubMed ID: 31270080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does TAL-1 deletion contribute to the high incidence of T-cell acute lymphoblastic leukemia in South Indian patients?
    Sudhakar N; Nirmala K; Rajalekshmy KR; Rajkumar T
    Asian Pac J Cancer Prev; 2008; 9(1):127-30. PubMed ID: 18439091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group.
    D'Angiò M; Valsecchi MG; Testi AM; Conter V; Nunes V; Parasole R; Colombini A; Santoro N; Varotto S; Caniglia M; Silvestri D; Consarino C; Levati L; Magrin E; Locatelli F; Basso G; Foà R; Biondi A; Cazzaniga G
    Haematologica; 2015 Jan; 100(1):e10-3. PubMed ID: 25304610
    [No Abstract]   [Full Text] [Related]  

  • 20. [Genetic basis of pediatric T-cell acute lymphoblastic leukemia and its clinical impact].
    Takita J
    Rinsho Ketsueki; 2018; 59(7):953-959. PubMed ID: 30078808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.